Stockreport

Roche boosts Olema after additional late-stage trial data for breast cancer drug [Seeking Alpha]

Olema Pharmaceuticals, Inc.  (OLMA) 
PDF selective estrogen receptor degrader (SERD) giredestrant, sending the shares of Olema Pharmaceuticals ( OLMA ), which is advancing a similar treatment, ~10% higher Bas [Read more]